middle.news
Memphasys Hits $102K Revenue Milestone After CE Mark Approval
9:42am on Thursday 22nd of January, 2026 AEDT
•
Biotechnology
Read Story
Memphasys Hits $102K Revenue Milestone After CE Mark Approval
9:42am on Thursday 22nd of January, 2026 AEDT
Key Points
First material revenues of approximately $102,000 invoiced in December quarter
CE Mark approval secured, enabling sales across Europe and CE-recognised regions
Multi-year contracts signed with Centro Fertilità Assistita (Italy) and International Technical Legacy (Middle East)
New supply agreement entered in India, expanding access to 200+ IVF clinics
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE